MustGrow Biologics Corp. (TSXV:MGRO)
Canada · Delayed Price · Currency is CAD 0.7100
-0.0100 (-1.39%)
Aug 12, 2025, 10:03 AM EDT
Lumos Pharma Revenue
MustGrow Biologics had revenue of 3.78M CAD in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 4.18M, down -11.30% year-over-year. In the year 2024, MustGrow Biologics had annual revenue of 398.02K, down -91.55%.
Revenue (ttm)
4.18M
Revenue Growth
-11.30%
P/S Ratio
8.90
Revenue / Employee
n/a
Employees
n/a
Market Cap
37.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 398.02K | -4.31M | -91.55% |
| Dec 31, 2023 | 4.71M | 4.71M | 72,630.36% |
| Dec 31, 2022 | 6.48K | -6.39K | -49.65% |
| Dec 31, 2021 | 12.87K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wheaton Precious Metals | 2.27B |
| Barrick Mining | 18.85B |
| Franco-Nevada | 1.80B |
| Nutrien | 34.13B |
| Kinross Gold | 8.28B |
| Teck Resources | 9.96B |
| First Quantum Minerals | 6.75B |
| Lundin Gold | 2.01B |
MustGrow Biologics News
- 2 months ago - MustGrow Biologics GAAP EPS of -C$0.03 - Seeking Alpha
- 3 months ago - MustGrow Biologics accelerates regenerative agriculture with NexusBioAg acquisition - BNN Bloomberg
- 8 months ago - MustGrow Biologics proposes ~$2M private placement - Seeking Alpha